Search
for
Sort by
Research 30 of 1000+
- Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial
- Evaluation of Five Hundred Patients using Ahmad’s NPRT System for Documenting Male Pattern Baldness
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
- Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial
- P153 : Safety and Efficacy of botulinum toxin on male pattern baldness
- The use of botulinum toxin in the treatment of male pattern baldness
- A Randomized Controlled, Single-Observer Blinded Study on the Safety and Efficacy of a Combination of 678nm Helmet-Type Low-level Laser Therapy and Topical Minoxidil 5% Versus Topical Minoxidil 5% Alone in the Treatment of Male Androgenetic Alopecia
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Male pattern androgenetic alopecia in an Indian context: a perspective study
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- A Genetically Defined Male Counterpart of Polycystic Ovary Syndrome: Evidence for Ovarian-Independent Pathogenesis
- In silico screening of effective inhibitor of 5α-reductase type 1 for androgenic alopecia treatment
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- What Is the Male Polycystic Ovary Syndrome Phenotype?
- ST008 Male androgenetic alopecia: A new treatment paradigm
- Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology
- Identification of immune microenvironment changes, immune-related pathways and genes in male androgenetic alopecia
- Delayed Diagnosis of Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
- Identification of Immune Microenvironment Changes, Immune-Related Pathways and Genes in Male Androgenetic Alopecia
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- A Study on Association between Androgenetic Alopecia and Cardiovascular Risk Factors in Males with History of Hair Fall
- Prevalence of androgenetic alopecia in China: a community-based study in six cities
- Efficacy of two traditionally used potentized homeopathic medicines, Calcarea carbonica and Lycopodium clavatum, used for treating PCOS patients: I. Effects on certain important external guiding symptoms
- Antiandrogens — Basic Concepts for Treatment
- Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report
- Minigraft Preparation in Surgical Hair Replacement
- Analysis of familial factors using the basic and specific (BASP) classification in Korean patients with androgenetic alopecia